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The six-transmembrane protein GDE2 controls the
onset and progression of spinal motor neuron differ-
entiation through extracellular glycerophospho-
diester phosphodiesterase metabolism. Although
this process is likely to be tightly regulated, the
relevant mechanisms that modulate its activity are
unknown. Here we show that the antioxidant scav-
enger peroxiredoxin1 (Prdx1) interacts with GDE2,
and that loss of Prdx1 causes motor neuron deficits
analogous to GDE2 ablation. Prdx1 cooperates with
GDE2 to drive motor neuron differentiation, and this
synergy requires Prdx1 thiol-dependent catalysis.
Prdx1 activates GDE2 through reduction of an intra-
molecular disulfide bond that bridges its intracellular
N- and C-terminal domains. GDE2 variants incapable
of disulfide bond formation acquire independence
from Prdx1 and are potent inducers of motor neuron
differentiation. These findings define Prdx1 as a
pivotal regulator of GDE2 activity and suggest roles
for coupled thiol-redox-dependent cascades in con-
trolling neuronal differentiation in the spinal cord.
INTRODUCTION
The assembly of functional neural circuits depends upon
the precisely controlled temporal and spatial differentiation of
distinct neuronal subtypes (Jessell, 2000; Kintner, 2002).
Deregulated differentiation can lead to severe deficits including
the depletion of progenitor pools, imbalances in neuronal diver-
sity and number, and at the other extreme, unchecked prolifera-
tion and tumor formation (Bertram, 2000; Kintner, 2002).
Although the transcriptional pathways that control the transition
between proliferation and differentiation are emerging, the regu-
latory mechanisms that control this switch are poorly understood
(Jessell, 2000).
The differentiation of spinal motor neurons has proved to be
a useful paradigm to understand the molecular mechanisms
that control neuronal differentiation (Jessell, 2000). RetinoicCacid (RA) signals trigger the differentiation of motor neuron
progenitors into postmitotic motor neurons in part by downregu-
lating Olig2, which maintains cells in a motor neuron progenitor
state (Mizuguchi et al., 2001; Novitch et al., 2001, 2003; Lee
et al., 2005). Decreased Olig2 expression causes a change in
the equilibrium of Olig2 and the proneural protein Ngn2, causing
the parallel implementation of neurogenic and motor neuron fate
specification programs (Lee et al., 2005). These events correlate
with changes in cell-body position along the medial-lateral axis
of the spinal cord that accurately reflect the progress of motor
neuron differentiation (Jessell, 2000; Hollyday, 2001). Thus,
actively cycling Olig2+ motor neuron progenitors reside within
the ventricular zone (VZ), but after completing their terminal
mitosis at the medial margin of the VZ, Olig2+ progenitors
undergo cell-cycle arrest and migrate laterally into the interme-
diate zone (IZ) (Figure S1 available online) (Hollyday, 2001).
Subsequently, differentiating cells in the IZ downregulate pro-
genitor markers, express postmitotic motor neuron markers
such as Islet1 and HB9, and migrate laterally to occupy their final
settling positions in the ventral horn (Figure S1) (Jessell, 2000;
Hollyday, 2001).
The molecular pathways that link RA signaling pathways to the
transcriptional programs that regulate the transition from prolif-
eration to differentiation are beginning to emerge. RA signaling
triggers motor neuron differentiation by upregulating GDE2,
a six-transmembrane protein containing an extracellular glycer-
ophosphodiester phosphodiesterase (GDPD) domain. GDE2 is
necessary and sufficient to drive motor neuron differentiation
by coordinately triggering neurogenic and motor neuron fate
specification pathways (Nogusa et al., 2004; Rao and Sockana-
than, 2005; Yanaka et al., 2007). Single point mutations that
negate GDE2 GDPD function fail to induce motor neuron differ-
entiation, revealing GDE2 as a signaling system that drives motor
neuron differentiation through extracellular GDPD activity (Zheng
et al., 2003; Santelli et al., 2004; Rao and Sockanathan, 2005).
GDE2 belongs to a vertebrate-specific family of six-transmem-
brane GDPD-containing proteins that includes GDE3 and
GDE6 (Nogusa et al., 2004; Yanaka et al., 2003; Yanaka, 2007).
GDE3 is capable of driving osteoblast differentiation in vitro,
suggesting that these proteins are a unique family of signaling
molecules that critically regulate differentiation in diverse cellular
contexts (Yanaka et al., 2003; Yanaka, 2007).ell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc. 1209
Figure 1. Prdx1 Interacts and Overlaps with GDE2 in the Ventral Spinal Cord
(A) Silver-stained SDS-PAGE gel shows a 23 kDa band (arrow) coimmunoprecipitates with GDE2. NLZ, control plasmid; GDE2, pCAGGS-GDE2NLZ.
(B and E) Tryptic peptides (red) from LC-MS/MS analyses of proteins derived from the 23 kDa band correspond to human (B) and chick Prdx1 (E).
(C, D, and F) In situ hybridization of Gde2 and Prdx1mRNA, and immunohistochemical analyses on transverse sections of St 19-20 chick spinal cords. Prdx1 and
GDE2 proteins colocalize in intermediate (IZ) and marginal zone (MZ) cells but not in ventricular zone progenitors (VZ).
(G) Coimmunoprecipitates of transfected HEK293T cells show HA-tagged Prdx1 interacts with the N terminus of GDE2.Loss of GDE2 leads to deficits in motor neuron production,
whereas premature exposure of progenitors to GDE2 GDPD
signals precipitates differentiation and the depletion of progeni-
tors (Rao and Sockanathan, 2005). Thus, the precise regulation
of GDE2 activity is a critical prerequisite for the normal progres-
sion of spinal motor neuron differentiation. However, virtually
nothing is known of the mechanisms that control GDE2 function,
and how it integrates with cellular regulatory networks. In order
to define the mechanisms that regulate GDE2 function, we
carried out unbiased proteomic screens to isolate proteins that
interact with GDE2. Here, we identify the antioxidant enzyme
Prdx1 as an interactor of GDE2 and uncover a developmental
role for Prdx1 in regulating neuronal differentiation in the spinal
cord. Prdx1 is a 2-cysteine (Cys) thiol reductase that forms
a component of cellular antioxidant and thermal stress defense
mechanisms through its ability to metabolize H202, and its prop-
erties as a molecular chaperone (Wood et al., 2003; Rhee et al.,
2005; Jang et al., 2004). We show here that Prdx1 is expressed in
differentiating progenitors in the developing spinal cord. Ablation
of Prdx1 causes deficits in motor neuron differentiation but no
changes in the specification or number of Olig2+ progenitors,
reminiscent of GDE2 loss of function phenotypes. Prdx1 binds
and activates GDE2 by causing the reduction of an intramolecu-
lar disulfide bond between the N- and C-terminal domains of
GDE2 that normally gates its function. Single point mutants of
GDE2 that fail to form the intramolecular disulfide bridge are
potent inducers of motor neuron differentiation, and gain inde-
pendence from Prdx1 regulation. Our findings extend to the1210 Cell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inccontrol of spinal interneuron differentiation, implicating thiol
redox pathways as key controllers of neuronal differentiation in
the spinal cord.
RESULTS
The Antioxidant Enzyme Prdx1 Interacts with GDE2
To identify molecules that regulate GDE2 function, we carried out
unbiased screens for GDE2-interacting proteins using large-
scale immunoprecipitation of FLAG-tagged GDE2 containing
complexes followed by Liquid Chromatography-Mass Spec-
trometry/Mass Spectrometry (LC-MS/MS). Extracts derived
from embryonic chick spinal cords electroporated with plasmids
expressing FLAG-GDE2 were analyzed to identify neural specific
GDE2 interactors, and extracts prepared from FLAG-GDE2-
transfected HEK293T cells were utilized to identify general
interactors of GDE2. LC-MS/MS analyses of component pro-
teins from GDE2 complexes immunoprecipitated from both
sources identified Prdx1 as a GDE2-interacting protein (Figures
1A, 1B, and 1E). We confirmed the interaction between Prdx1
and GDE2 by coimmunoprecipitation, using extracts prepared
from HEK293T cells transfected with epitope-tagged versions
of Prdx1 and GDE2 (Figures 1G and S2). GDE2 mutants lacking
the intracellular N-terminal domain (GDE2DN38) failed to interact
with Prdx1, indicating that Prdx1 associates with the N-terminal
38 amino acids of GDE2 (Figure 1G). Analyses of Prdx1 mRNA
and protein on sections of chick embryonic spinal cord spanning
the peak period of motor neuron differentiation show that.
Prdx1 is expressed in progenitor cells located in the VZ prior
to the onset of GDE2 expression, but overlaps with GDE2 in IZ
cells and postmitotic motor neurons in the MZ (Figures 1C, 1D,
and 1F).
Prdx1 Is Required for Motor Neuron Differentiation
The coincident expression of Prdx1 and GDE2 and their ability to
associate raise the possibility that Prdx1/GDE2 complexes func-
tion to control motor neuron differentiation. To determine the
consequences of loss of Prdx1 on spinal motor neuron differen-
tiation, we ablated Prdx1 expression in vivo. Twenty-one base
pair double-stranded RNA oligonucleotides designed against
the Prdx1 coding sequence were electroporated into developing
chick spinal cords at Hamburger Hamilton stage (St) 11, prior to
the initiation of motor neuron differentiation (Rao et al., 2004).
Embryos electroporated with Prdx1 siRNA showed complete
ablation of Prdx1 mRNA expression and a dramatic reduction
in Prdx1 protein (Figures 2A and 2B).
Immunohistochemical analyses of motor neuron progenitor
and postmitotic markers on serial sections of embryos electro-
porated with Prdx1 siRNA show that Prdx1 silencing caused
the loss of approximately 50% of Islet1+ (or Isl1+), HB9+, and
Islet2+ (or Isl2+) motor neurons but did not alter the number of
Olig2+ motor neuron progenitors or the dorsal-ventral patterning
of spinal progenitors (Figures 2C–2G and S3). No increase in TU-
NEL staining was detected, suggesting that the loss of Prdx1 did
not compromise motor neuron survival (Figure S4). This is in
contrast with siRNA ablation of Gde2 and might reflect addi-
tional functions for GDE2 in postmitotic motor neurons (Rao
and Sockanathan, 2005). The siRNA-dependent silencing of
Prdx1 is specific, as Prdx1 knockdown could be titrated with
differing amounts of Prdx1 siRNA; unrelated siRNAs did not
trigger Prdx1 silencing; Prdx1 siRNA did not induce global
changes in gene expression; and coelectroporation of con-
structs expressing human Prdx1, which is insensitive to the
siRNA, rescued the motor neuron phenotype (Figures S3 and
S5). Thus, Prdx1 is required for the formation of postmitotic
motor neurons but not for earlier events in motor neuron progen-
itor specification, similar to the function of GDE2 (Rao and Sock-
anathan, 2005).
Aged Prdx1-null mice develop hemolytic anemia and acquire
multiple malignancies, indicative of a tumor suppressor func-
tion for Prdx1 (Neumann et al., 2003; Egler et al., 2005). To
determine whether Prdx1/ animals exhibit deficits in spinal
motor neuron development, we analyzed Prdx1/ embryos
at E9.5 during the peak period of motor neuron differentiation.
Prdx1/ animals do not express Prdx1 transcripts, consistent
with previous studies demonstrating the absence of Prdx1
protein in these mutants (Figures 3A and 3E) (Neumann et al.,
2003; Egler et al., 2005). Prdx1/ mutants revealed similar
phenotypes to chick embryos electroporated with Prdx1 siR-
NAs. Prdx1/ embryos lost approximately 50% of Islet1/
Islet2+ and HB9+ motor neurons compared with wild-type
(WT) littermates, whereas dorsal-ventral patterning events and
the numbers of Olig2+ progenitors were normal (Figures 3B–
3D, 3F, 3G, and S3). Toward the end of the cell death phase
at E16.5, Prdx1-null, and WT embryos had equivalent numbers
of motor neurons (data not shown). The incomplete ablation ofmotor neurons in Prdx1/ embryos might be a consequence
of redundant functions of other Prdx proteins that regulate
cellular differentiation such as Prdx2, which is expressed in
the ventral mouse spinal cord and is capable of binding GDE2
or alternatively, redundancy with other known signaling path-
ways that regulate differentiation in the spinal cord (Figure S6)
(Choi et al., 2005).
TUNEL analysis showed no difference in cell death between
Prdx1/ and WT embryos, suggesting that Prdx1 regulates
the differentiation of motor neurons rather than their survival
(Figure S4). To explore this possibility in more detail, we
compared the frequency of cell-cycle exit between Prdx1/
and WT embryos at the peak period of motor neuron
Figure 2. Prdx1 Is Required for Motor Neuron Generation
(A–F) In situ hybridization (A) and immunohistochemical analyses (B–F) of
transverse sections of St 20-21 chick spinal cords electroporated with Prdx1
siRNAs (left). HB9+ motor neurons are visualized in red in (D).
(G) Graph shows reduction of postmitotic motor neurons on Prdx1 silencing.
Con, nonelectroporated side; EP, electroporated side (mean ± standard
error of the mean [SEM]); *HB9, p = 0.000004; Islet1/2, p = 0.00001; Isl1,
p = 0.00009; Isl2, p = 0.00008; Olig2, p = 0.2; paired Student’s t test, n = 6.Cell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc. 1211
differentiation. We injected pregnant dams with BrdU to label
cells in S phase, harvested embryos 16 hr later, and calculated
the cell-cycle exit index by analyzing the ratio of nonproliferating
to proliferating BrdU+ cells in the ventral spinal cord. At E9.5,
there was a marked reduction in the cell-cycle exit index
of Prdx1/ embryos compared with WT littermates, but no
differences in independent studies of cell-cycle progression at
S and M phase (Figures 3H–3N). Thus, Prdx1 is required for
the differentiation of postmitotic motor neurons during the
Figure 3. Prdx1/ Embryos Show Deficits
in Motor Neuron Generation
(A–N) In situ hybridization (A and E) and immuno-
histochemical analyses (B, C, F, G, H–J, and
L–N) of transverse sections of mouse E9.5
Prdx1+/+ and Prdx1-null spinal cords. In (D),
graphs show motor neuron loss in Prdx1 nulls
(mean ± SEM). *HB9, p = 0.00054, *Isl1/2, p =
0.0004; Olig2, p = 0.69; two-tailed Student’s
t test, n = 5. In (K), graphs show deficits in cell-
cycle exit in Prdx1 nulls (mean ± SEM). *Cell-cycle
exit, p = 0.0002; S phase, p = 0.63; M phase,
p = 0.8; two-tailed Student’s t test, n = 5.
(O–Q and S–U) Immunohistochemical analyses of
transverse sections of mouse E9.5 spinal cords.
(R) Graphs show motor neuron loss in double
heterozygotes for Prdx1 and Gde2 (mean ± SEM).
Two-way analysis of variance shows significant
interaction between GDE2 and Prdx1; *HB9,
p = 0.00783; *Isl1/2, p = 6.54 3 105; Olig2,
p = 0.72; n = 5.
peak period of neurogenesis, but not for
motor neuron progenitor specification or
proliferation.
Prdx1 Synergizes with GDE2 to
Drive Spinal Neuron Differentiation
The similarity between the loss of function
phenotypes between Prdx1 and GDE2
suggests that they operate within the
same pathway to regulate motor neuron
differentiation. To test this possibility, we
carried out gene dosage experiments by
generating mice heterozygous for Gde2
and Prdx1. At the peak of spinal motor
neuron differentiation, WT, Prdx1+/ and
Gde2+/ animals contain comparable
numbers of Olig2+ motor neuron progen-
itors and HB9+ and Islet1/2+ motor
neurons (Figures 3O–3U). In contrast,
double-heterozygous Prdx1+/; Gde2+/
embryos exhibit an approximately 40%
and 30% reduction in HB9+ and Islet1/
2+ motor neurons, respectively, while
retaining equivalent numbers of Olig2+
motor neuron progenitors to controls
(Figures 3P, 3T, and 3R). This observation
provides strong genetic evidence that
Prdx1 and GDE2 function within the same pathway to control
motor neuron differentiation.
To investigate the synergy between Prdx1 and GDE2 in
promoting motor neuron differentiation, we performed in vivo
gain of function assays using in ovo electroporation of embryonic
chick spinal cords. We engineered expression constructs
placing an HA-tagged version of Prdx1 under the control of the
chick b-actin promoter (pCAGGS-Prdx1) and bicistronic
constructs expressing GDE2 (pCAGGS-GDE2IRESnLacZ). As1212 Cell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc.
Figure 4. Prdx1/GDE2 Complexes Drive Motor Neuron Differentiation In Vivo
(A–N) Immunohistochemical analyses of transverse sections of ventral St 19-20 chick spinal cords electroporated (left) with GDE2 and Prdx1. Arrowheads mark
terminally differentiated neurons in the ventricular zone (VZ). The VZ was defined by BrdU pulse labeling to mark S-phase cells at lateral margins. Midline: vertical
arrow, VZ: horizontal arrow. (M) and (N) show the same section stained with HA and LacZ to detect Prdx1 and GDE2, respectively.
(O) Graph quantifying ectopic motor neurons in the VZ of electroporated embryos (mean ± SEM; n = 5–10). Prdx1 overexpression weakly induces ectopic motor
neurons, presumably through interactions with GDE2-related proteins in VZ cells such as GDE6 (S.S., unpublished data).described previously, overexpression of GDE2 in cycling
progenitors caused many cells to differentiate into postmitotic
motor neurons prematurely; in contrast, overexpression of
Prdx1 induced very few Islet1/2+ motor neurons (Figures 4A,
4B, and 4O) (Rao and Sockanathan, 2005). To determine
whether Prdx1 and GDE2 cooperate to induce motor neuron
differentiation, we coexpressed Prdx1 and a suboptimal amount
of GDE2 in the spinal cord that normally does not give rise to
motor neurons (0.5 X GDE2; Figures 4C and 4O). Coelectropora-
tion of Prdx1 and GDE2 generated many ectopic Islet1/2+ motor
neurons in the VZ in numbers that exceeded that of Islet1/2+ cells
induced when optimal amounts of GDE2 alone are electropo-
rated (Figures 4A, 4D, and 4O). The ectopic Islet1/2+ motor
neurons bore the hallmarks of motor neurons generated by
GDE2 activity: they had downregulated progenitor markers
such as Sox1 and Olig2, they had exited the cell cycle as as-
sessed by the lack of BrdU incorporation, and they expressed
the postmitotic marker p27 and the motor neuron markers Islet2
and HB9 (Figures 4I–4L and data not shown) (Rao and Sockana-than, 2005). Furthermore, 30% of the ectopic motor neurons did
not express Prdx1 or GDE2, consistent with the ability of GDE2
to promote non-cell-autonomous motor neuron differentiation
(Figures 4M and 4N) (Rao and Sockanathan, 2005). Thus,
Prdx1 synergizes with GDE2 to promote motor neuron differen-
tiation in vivo. Prdx2 can similarly cooperate with GDE2 to drive
motor neuron differentiation, consistent with redundant func-
tions for 2-Cys Prdx proteins in controlling GDE2-dependent
motor neuron differentiation (Figure S6).
Strikingly, coexpression of Prdx1 and GDE2 in the dorsal
spinal cord led to a similar induction of p27 and concomitant
downregulation of Sox1 in VZ progenitors (Figures 5A–5D).
Further, these medially located postmitotic cells expressed
appropriate postmitotic interneuron markers specific to their
dorsal-ventral position, suggesting that Prdx1 and GDE2 coop-
erate to promote the differentiation of diverse interneuron
subtypes (Figures 5E–5I). This observation is consistent with
the dorsal expression of Prdx1 in IZ cells, and the dorsal expan-
sion of GDE2 expression, which coincides with the temporalCell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc. 1213
Figure 5. GDE2 and Prdx1 Regulate Spinal Interneuron Differentiation
(A–D and F–Q) Immunohistochemical analysis of transverse sections of St 20-21 dorsal chick spinal cords, electroporated on the left. Arrows mark the midline.
VZ, ventricular zone; double-headed arrows, VZ extent; Prdx1*, Prdx1C52.173.S.
(E) Schematic of the spinal cord showing the location of dorsal (dI1-6) and ventral (V0-V3) interneurons in relation to motor neurons (MN).
(F–I) Prdx1 and GDE2 overexpression induces multiple interneuron subtypes in spinal progenitors (defined by their molecular gene expression profiles; Helms and
Johnson, 2003) within their respective dorsal-ventral domains.
(J–M) Ablation of Prdx1 by electroporation of siRNA reduces the number of dorsal and ventral spinal interneurons.
(N–Q) Spinal interneuron populations are rescued by electroporation of human Prdx1, which is insensitive to the electroporated Prdx1 siRNA.profile of spinal neurogenesis. In support of this model, ablation
of Prdx1 expression by siRNA caused a loss of dI2-d6 dorsal
interneurons and ventral interneuron subclasses, suggesting
general roles for GDE2 and Prdx1 in controlling neuronal differ-
entiation in the spinal cord (Figures 5J–5Q).1214 Cell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc.Prdx1/GDE2 Properties Necessary for Motor Neuron
Induction
We utilized the synergistic gain of function assay to define the
basis of the cooperativity between GDE2 and Prdx1. To deter-
mine whether physical interaction between GDE2 and Prdx1 is
required for premature motor neuron induction, we coelectropo-
rated expression constructs for Prdx1 and GDE2DN38 into chick
spinal cords. GDE2DN38 lacks the Prdx1 interaction domain
and is expressed and transported to the membrane at similar
levels as GDE2 (Figures 1 and S7). Coexpression of GDE2DN38
and Prdx1 failed to induce ectopic Islet1/2+ motor neurons in
the VZ, suggesting that Prdx1 functions in a complex with
GDE2 to regulate motor neuron differentiation (Figures 4E and
4O). Both GDE2 and Prdx1 contain catalytic domains that are
essential for their functions. Mutation of a histidine residue to
alanine within the GDE2 GDPD domain severely impairs its ability
to drive motor neuron differentiation (GDE2H275A), whereas
mutation of the reactive Cys (Prdx1C52.173S) or an arginine
residue located near the Prdx1 active site (Prdx1R128E) abolishes
Prdx1 catalytic activity (Jang et al., 2004; Zheng et al., 2003;
Rao and Sockanathan, 2005; Montemartini et al., 1999;
Flohe et al., 2002). Coimmunoprecipitation assays show that
GDE2H275A, Prdx1C52.173S, and Prdx1R128E retain their ability
to form complexes with WT Prdx1 and GDE2, respectively
(Figure S8). GDE2H275A did not synergize with Prdx1 to promote
premature motor neuron differentiation, whereas coexpression
of Prdx1C52.173S or Prdx1R128E with GDE2 in chick spinal cords
did not induce ectopic Islet1/2+ motor neurons in the VZ (Figures
4F–4H and 4O). These observations confirm that GDE2 GDPD
activity is required for GDE2/Prdx1 complexes to promote
motor neuron differentiation. Moreover, they reveal that Prdx1
catalytic activity is required for the ability of GDE2 to regulate
motor neuron differentiation, and further argue against a molec-
ular chaperone function for Prdx1 in this context, because
Prdx1C52.173S mutants retain effective chaperone activity in the
absence of elevated H2O2 (Jang et al., 2004).
Prdx1 Reduces an Intramolecular Disulfide Bond
within GDE2
How does Prdx1 catalytic activity regulate GDE2 function?
The yeast Gpx3 and TSA peroxiredoxins can induce disulfide
bond formation in the redox-response transcription factor
Yap1 under conditions of oxidative stress, whereas the bacterial
peroxiredoxin AhpC has in vitro disulfide reductase activity
(Delaunay et al., 2002; Ritz et al., 2001). To evaluate whether
Prdx1 is capable of modifying GDE2 disulfide bond formation,
we compared the presence of free thiol groups in GDE2 in the
absence or presence of Prdx1 using 4-acetamido-40-maleimidyl-
stilbene-2,20-disulfonic acid (AMS), a thiol-conjugating reagent
that decreases the electrophoretic mobility of bound proteins
by 0.5 kDa/free thiol (Sevier et al., 2007). Western blot analyses
of deglycosylated surface biotinylated GDE2 in HEK293T cells
showed a decrease in GDE2 mobility in the presence of AMS,
indicating that GDE2 at the cell surface normally contains free
thiols (Figure 6A). When Prdx1 is coexpressed with GDE2, there
was a small but reproducible shift in the mobility of GDE2 by
AMS modification consistent with an increase of free thiol groups
(Figure 6A). The Prdx1-dependent decrease in GDE2 mobility
requires Prdx1 redox activity because the catalytically inactive
Prdx1C52.173S mutant fails to alter GDE2 migration (Figure 6A).
GDE2 contains three closely spaced Cys residues within
its intracellular N-terminal region (C15, C18, C25) and one
Cys within its C-terminal domain (C576) (Figure 6B). To identifyCthe Cys residues reduced by Prdx1, we mutated the C15 and
C18 residues (GDE2C15.18S), and the C25 and C576 residues
(GDE2C25.576S) of GDE2 to serine. Both GDE2C15.18S and
GDE2C25.576S retained the ability to bind Prdx1 and are ex-
pressed at the membrane at equivalent levels (Figures S7 and
S9). Coexpression of Prdx1 and GDE2C15.18S in HEK293T cells
caused a shift in GDE2 mobility by AMS modification, similar to
that observed when Prdx1 and WT GDE2 are cotransfected
(Figure 6A). Because C25 and C576 are the only intracellular thiol
groups available in GDE2C15.18S, this result suggests that Prdx1
causes the reduction of a disulfide bond normally formed
between the C25 and C576 residues of GDE2. Consistent with
this observation, Prdx1 did not alter the mobility of GDE2C25.576S
modified by AMS (Figure 6A).
To investigate the effect of Prdx1 on GDE2 further, we utilized
biochemical assays adapted to detect the presence of disulfide
bonds in GDE2 in transfected HEK293T cells (Leichert and Jakob,
2004). Free thiol groups in GDE2 were blocked by N-ethylmalei-
mide (NEM) prior to the stepwise addition of Tris (2-carboxyethyl)
phosphine (TCEP) and N-(6-(biotinamido)hexyl)-30-(20-pyridyldi-
thio)-propionamide (biotin-HPDP), which respectively causes
the reduction of disulfide bonds and the modification of resultant
free thiols by biotin. Western blotting of immunoprecipitated
GDE2 shows that in the absence of TCEP, GDE2 was not labeled
by biotin, demonstrating effective blockade of free thiols in GDE2
(Figure 6C). Addition of TCEP resulted in biotinylated GDE2,
consistent with the reduction and labeling of endogenous disul-
fide bonds in GDE2 (Figure 6C, GFP). However, coexpression
of Prdx1 with GDE2, but not the redox-inactive Prdx1C52.173S
mutant, decreased the amount of biotinylated GDE2, suggesting
that Prdx1 catalytic activity causes reduction of disulfide bonds
within GDE2 (Figure 6C). Analysis of GDE2 Cys mutants showed
that although a similar reduction of biotinylated GDE2C15.18S was
observed in the presence of Prdx1, no changes in biotin labeling
of GDE2C25.576S were detected (Figure 6C), consistent with our
AMS data and the model that Prdx1 can cause reduction of the
C25-C576 disulfide bond in GDE2.
The C25-C576 disulfide bridge is unusual given the reducing
environment of the cell; thus, we utilized LC-MS/MS to confirm
that C25 and C576 participate in disulfide bond formation in
transfected HEK293T cells. Free thiol groups were blocked by
NEM prior to reduction by DTT and subsequent thiol modifica-
tion by iodoacetamide (IAM). LC-MS/MS analysis revealed that
C576 was labeled by NEM and IAM, suggesting that C576
participates in disulfide bond formation and that this disulfide
bond is dynamic (Figure 6E and S10). To examine if Prdx1 leads
to the reduction of GDE2 disulfide bonds utilizing C576, we
compared the relative signal intensities of GDE2 peptides con-
taining C576 NEM and C576 IAM by LC-MS/MS in the absence
and presence of Prdx1. In the absence of Prdx1, the relative
intensities of both peptides were approximately similar. GDE2
and Prdx1 coexpression led to a 5- to 6-fold increase of C576
NEM labeling compared with C576 IAM, suggesting that Prdx1
shifts the equilibrium of C576 to a reduced state (Figure 6E). In
addition, LC-MS/MS analysis showed that C25 can be labeled
by IAM (data not shown). These collective observations are
consistent with our AMS and biotin labeling experiments, and
support the model that Prdx1 catalytic activity causes reductionell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc. 1215
Figure 6. Prdx1 Reduces an Intracellular Disulfide Bridge in GDE2
(A) Western blots of AMS-modified surface biotinylated GDE2 in transfected HEK293T cells. Red dots mark horizontal position of the bands. Similar results were
obtained with total protein. Addition of DTT caused further shifts in GDE2 mobility consistent with the presence of additional disulfide bonds in GDE2. MS analysis
reveals that C15 and C18 can form a disulfide bond that is insensitive to Prdx1 activity (data not shown).
(B) Schematic of intracellular cysteines in GDE2. Other cysteines are not marked.
(C) Western blots of immunoprecipitated GDE2 detecting biotinylated GDE2 compared with GDE2. Graphs quantify the amount of biotinylated GDE2 normalized
to total GDE2, mean ± SEM, GDE2 + GFP values are normalized to 1, GDE2 + Prdx1 *p = 6.4 3 1018, GDE2C15.18S + Prdx1 *p = 2.05 3 1013, GDE2C25.576S +
Prdx1 p = 0.27; n = 7 assays; one sample Student’s t test.
(D) Nonreducing gels of GDE2 coimmunoprecipitates from transfected HEK293T cells with or without b-mercaptoethanol (b-ME). Arrow represents 120–130 kDa
mixed-disulfide Prdx1/glycosylated GDE2 intermediate. Black circles represent nonspecific bands; open circles, higher order Prdx1-containing oligomers, Prdx1
monomers. The band comigrating with the Prdx1 monomer in lane 1 is not specific and forms a minor component when Prdx1 complexes interacting with GDE2
are reduced by b-ME.
(E) Relative signal intensities of GDE2 C-terminal peptides containing C576 labeled with IAM (C; oxidized thiol) or NEM (C#; free thiol) in the absence or presence
of Prdx1. Ratio = NEM/IAM.of an intramolecular disulfide bond formed between C25 and
C576 of GDE2.
Prdx1 and GDE2 Form a Disulfide Intermediate
If Prdx1 directly reduces a disulfide bond formed between C25
and C576 in GDE2, then GDE2 and Prdx1 should form a transient1216 Cell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc.mixed-disulfide intermediate during the transfer reaction (Sevier
and Kaiser, 2002). To address this question, we coimmunopreci-
pitated GDE2 containing complexes from extracts prepared
from HEK293T cells transfected with Prdx1 and GDE2. Analysis
of Prdx1 redox state in transfected extracts shows that Prdx1
exists in reduced and oxidized forms (Figure S8). Western blots
show that forms of Prdx1 associated with GDE2 include reduced
monomers, high-molecular-weight complexes and a band of
approximately 120–130 kDa that corresponds to the predicted
molecular weight of a GDE2/Prdx1 complex (open circles, arrow,
Figure 6D). Addition of b-mercaptoethanol abolished formation
of the 120–130 kDa complex, suggesting that its assembly
utilizes disulfide bonds (Figure 6D). Coexpression of GDE2 and
Prdx1C52.173S, or GDE2C25.576S and Prdx1, failed to form the
120–130 kDa complex, though Prdx1C52.173S and GDE2C25.576S
retain their abilities to bind GDE2 and Prdx1, respectively
(Figures 6D, S8, and S9). In contrast, GDE2C15.18S, which
preserves the capacity to form an intracellular disulfide bond
between C25 and C576, can form the 120–130 kDa complex
(Figure 6D). These observations suggest that the 120–130 kDa
complex is a mixed-disulfide Prdx1-GDE2 intermediate, and
that the cysteines responsible for Prdx1 redox activity, and the
C25 or C576 residue in GDE2, participate in its formation.
GDE2C25.576S Is a Potent Inducer of Differentiation
that Is Independent of Prdx1
Our developmental and biochemical studies are consistent with
the model that Prdx1 directly activates GDE2 by reducing an
intracellular C25-C576 disulfide bond that bridges the N- and
C-terminal domains of GDE2. If so, then GDE2C25.576S, which
cannot form the disulfide bridge, should be more effective than
GDE2 in promoting motor neuron differentiation. In addition,
GDE2C25.576S should no longer cooperate with Prdx1 to induce
ectopic motor neurons in the VZ. To evaluate the activity of
GDE2C25.576S, we compared the ability of GDE2C25.576S and
GDE2 to induce ectopic Islet2+ motor neurons in the VZ of
embryonic chick spinal cords, using suboptimal amounts of
GDE2 that normally fail to elicit premature motor neuron differen-
tiation (Figures 4C, 4O, 7A, 7C, 7G, and 7H). In contrast to
GDE2, electroporation of suboptimal amounts of pCAGGS-
GDE2C25.576S effectively induced the differentiation of Islet2+
motor neurons in VZ progenitors (Figure 7C). Variants of GDE2
that contained a single point mutation converting the C25 or
C576 residue to serine (GDE2C25S, GDE2C576S) were similarly
effective (Figures 7D, 7E, 7G, and 7H). However, expression of
GDE2C15.18S, which retains the ability to form the C25-C576
disulfide bridge, showed similar activity as GDE2 in promoting
motor neuron differentiation under these conditions (Figure 7B,
7G, and 7H). Surface biotinylation and expression studies in
transfected HEK293T cells showed that GDE2, GDE2C25.576S,
GDE2C25S, GDE2C576S, and GDE2C15.18S are expressed at
similar levels on the cell membrane (Figure S7). These findings
extend to the differentiation of dorsal and ventral spinal interneu-
rons, and thus collectively imply that reduction of the C25-C576
disulfide bond between the N- and C-terminal domains of
GDE2 increases the efficacy of GDE2 to promote neuronal differ-
entiation, suggesting that the C25-C576 bridge normally gates
GDE2 function (Figures 7I–7P).
To test whether GDE2 mutants that fail to form the C25-C576
bridge cooperate with Prdx1 to promote motor neuron differen-
tiation, we electroporated suboptimal amounts of pCAGGS-
GDE2C25S into embryonic chick spinal cords, and compared
the ability of GDE2C25S to induce ectopic motor neurons in the
absence or presence of Prdx1. GDE2C25S is capable of bindingCPrdx1 and effectively induced Islet2+ motor neurons in the VZ
(Figures 7E, 7G, 7H, and S9). However, Prdx1 failed to potentiate
the ability of GDE2C25S to induce ectopic motor neurons, sug-
gesting that GDE2C25S does not require Prdx1 activity to drive
motor neuron differentiation (Figures 7F, 7G, and 7H). This
finding suggests that the major function of Prdx1 in the context
of the Prdx1/GDE2 complex is to reduce the C25-C576 disulfide
bridge that normally gates the ability of GDE2 to drive motor
neuron differentiation.
DISCUSSION
The antioxidant scavenger Prdx1 plays critical roles in the
defense of oxidative and thermal stress by its diverse abilities
to respectively metabolize H2O2 and act as a molecular chap-
erone (Wood et al., 2003; Rhee et al., 2005; Jang et al., 2004).
Using spinal motor neuron differentiation as a model system,
we have uncovered a previously uncharacterized developmental
role for Prdx1 in controlling neuronal differentiation. Our study
suggests a model where the overlap of Prdx1 and GDE2 expres-
sion in cells neighboring VZ progenitors permits the association
of Prdx1 with GDE2 (Figure 7Q). GDE2 is normally inactive due to
the presence of an intramolecular disulfide bond that links its
intracellular N- and C-terminal domains. However, once com-
plexed with GDE2, Prdx1 catalytic activity leads to reduction of
the GDE2 C25-C576 disulfide bond and activation of GDE2, trig-
gering motor neuron differentiation through extracellular GDE2
GDPD metabolism (Figure 7Q). These findings uncover critical
roles for thiol-redox-dependent mechanisms in activating
GDE2 signaling, and identify peroxiredoxins as pivotal regulators
of neuronal differentiation in the spinal cord.
Several lines of evidence suggest the intriguing possibility that
the requirement for Prdx1 in motor neuron differentiation stems
from a previously uncharacterized enzymatic function that is
distinct from its molecular chaperone or H2O2 metabolic activi-
ties. First, Prdx1 mutants that retain effective molecular chap-
erone activity but are catalytically inactive do not synergize
with GDE2 to drive premature motor neuron differentiation in
VZ progenitors. Second, loss of Prdx1 causes a deficit of post-
mitotic motor neurons in the absence of cell death. This observa-
tion is consistent with a role for Prdx1 in regulating motor neuron
differentiation, and argues against the possibility that motor
neuron survival is compromised through increased ROS levels
stemming from loss of Prdx1 scavenger function. Third, our
data suggest that Prdx1 activates GDE2 through thiol reductase
mechanisms that might not utilize H2O2 as a substrate, because
thiol modifications that utilize H2O2 metabolism are consistent
with oxidation rather than reduction. Although our data do not
rule out the formal possibility that Cys25 and Cys576 form
sulfenic acids rather than a disulfide bond, this appears unlikely
because sulfenic acids are considered very unstable and do not
form when in close proximity to other Cys residues (Paget and
Buttner, 2003). Our study thus poses a potential role for Prdx1
in directly regulating the activity of target proteins through disul-
fide bond reduction. In support of the dual enzymatic capabilities
of peroxiredoxins, bacterial AhpC, a typical 2-Cys peroxiredoxin
like Prdx1, exhibits disulfide reductase activity in vitro, and can
function as a biologically active disulfide reductase by theell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc. 1217
Figure 7. GDE2 Variants Incapable of Forming the N-C Disulfide Bridge Are More Active and Lose Prdx1 Synergy
(A–F) Immunohistochemical analyses of ventral and dorsal (I-P) St 19-20 electroporated chick spinal cords (left). Arrowheads mark Islet2+ motor neurons in the
ventricular zone (VZ). Vertical arrow, midline; horizontal arrow, VZ.
(G and H) Graphs quantifying the percentage of ectopic motor neurons relative to the number of transfected cells (LacZ) (G) and the number of ectopic motor
neurons (H) in the VZ (mean ± SEM; * = p < 0.001, two-tailed Student’s t test, n = 7–10; n.s., p > 0.5).
(Q) Model for Prdx1 regulation of GDE2-dependent neuronal differentiation. Reduced forms of Prdx1 bind to the N-terminus intracellular domain of GDE2. The
redox active Cys of Prdx1 forms a mixed-disulfide intermediate with GDE2. Here, C576 of GDE2 participates in a direct thiol-disulfide exchange, but C25 might be
utilized instead. Reduction of the GDE2 C25-C576 disulfide bond by Prdx1 activates GDE2, promoting differentiation via extracellular GDPD activity. Prdx1 is
oxidized during the reaction. The reduced form of Prdx1 might be a transient component of GDE2/Prdx1 complexes.addition of a single amino acid (Ritz et al., 2001). Nevertheless,
confirmation of the possible disulfide reductase activity of
Prdx1 awaits further investigation.
Actively cycling progenitors are inherently responsive to GDE2
GDPD differentiation signals and can undergo terminal differen-1218 Cell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc.tiation if prematurely exposed to GDE2 activity (Rao and Socka-
nathan, 2005). Thus, the precise regulation of GDE2 activity is
crucial to limit the exposure of GDPD differentiation signals to
only those progenitors that are poised to undergo differentiation
(Rao and Sockanathan, 2005). Our study suggests that this is
accomplished in part by the coexpression of Prdx1 and GDE2 in
IZ cells throughout the spinal cord, which restricts the formation
of active Prdx1/GDE2 complexes and the subsequent produc-
tion of GDPD differentiation signals to progenitors at the lateral
margin of the VZ. Other strategies to ensure a restricted zone
of GDPD-dependent signaling likely include mechanisms to
downregulate GDE2 activity. This could occur through the tar-
geted degradation of active, reduced disulfide forms of GDE2
through endocytic pathways; however, our surface biotinylation
studies argue against this scenario because WT and hyperactive
forms of GDE2 are present at equivalent amounts on the cell
membrane. An alternative mechanism to downregulate GDE2
activity is to regenerate the GDE2 C25-C576 disulfide bridge
through thiol oxidation. This mechanism poses that the C25-
C576 disulfide bridge functions as a reversible thiol-dependent
switch to control GDE2 function, and invokes the existence of
thiol oxidative proteins that negatively regulate GDE2 function.
Such redox-dependent recycling mechanisms are also likely
to apply to Prdx1. Prdx1-dependent activation of GDE2 should
result in the oxidation of the Prdx1 reactive Cys and inactivation
of Prdx1 catalytic activity. Consistent with this model, coexpres-
sion of Prdx1 and GDE2 increases the amount of oxidized Prdx1
(Figure S8). This implies that the progression of neuronal differ-
entiation relies upon the effective recycling of Prdx1 to active
reduced forms. Obvious candidates for reactivating Prdx1
include members of the Trx family of proteins, which are known
electron donors for Prdx1 (Rhee et al., 2005; Arne´r and Holmg-
ren, 2006). The need to recycle Prdx1 and downregulate GDE2
activity thus predicts that a cascade of coupled thiol-redox-
dependent pathways plays a central role in regulating the onset
and progression of motor neuron differentiation in the spinal
cord.
Our studies suggest that GDE2/Prdx1 complexes are not
limited to controlling motor neuron differentiation, but that they
also regulate the differentiation of dorsal and ventral spinal inter-
neurons. Our findings thus have potential implications for under-
standing general mechanisms that govern the transition between
cellular proliferation and differentiation. In the developing spinal
cord, progenitor proliferation is controlled by canonical Wnt
signaling pathways (Megason and McMahon, 2002; Zechner
et al., 2003). A recent report reveals that nucleoredoxin, a Trx
family member, inhibits proliferation by negatively regulating
b-catenin-mediated Wnt signaling through interactions with
Dishevelled (Funato et al., 2006). This observation, taken together
with our study, suggests the compelling possibility that Trx-Prdx-
coupled pathways form a thiol-redox-dependent cascade that
triggers the onset of neuronal differentiation in the spinal cord.
Trx proteins might have dual roles in inhibiting Wnt-dependent
progenitor proliferation and ensuring the availability of reduced
forms of Prdx proteins, which in turn, activate key modulators
of differentiation such as GDE2. Trx and Prdxs are widely
expressed, whereas GDE2 and its family members are expressed
in other regions of the central nervous system and nonneural
tissues such as the heart, lung, gut, and bone (Rhee et al.,
2005; Yanaka et al., 2003; Rao and Sockanathan, 2005). The
conservation of the N- and C-terminal Cys residues in GDE3
and GDE6, together with the coincident distribution of Trx,
2-Cys Prdxs and six-transmembrane GDPD proteins in variedcell types, suggests that coupled thiol-redox regulation of
GDPD signaling might constitute a key mechanism for regulating
cellular differentiation in diverse cellular contexts.
EXPERIMENTAL PROCEDURES
Immunoprecipitation and LC-MS/MS
N-terminal FLAG-tagged GDE2 or control vector was transfected into
HEK293T cells or electroporated into approximately 150–200 St 13 embryonic
chick spinal cords. Cell extracts and spinal cord lysates were harvested 24 hr
later and immunoprecipitated by anti-FLAG M2 Affinity gel (Sigma). Protein
complexes were resolved by SDS-PAGE, silver stained, and GDE2-specific
bands were excised and subjected to LC-MS/MS (Taplin Biological Mass
Spectrometry Facility, Harvard Medical School).
In Situ Hybridization and Immunofluorescence
In situ hybridization and immunostaining analyses were performed as previ-
ously described (Rao and Sockanathan, 2005). Details of antibodies are
provided in the Supplemental Experimental Procedures. TUNEL analysis
was performed using the ApopTag fluorescein in situ apoptosis detection kit
(Chemicon S7110). Confocal micrographs were captured on a Zeiss LSM 5
PASCAL microscope.
Loss- and Gain-of-Function Experiments
Chick embryos were electroporated with siRNA (Rao et al., 2004) and analyzed
40 hr later at St19-21. Then 10–20 sections from each of six embryos with at
least 80% loss of Prdx1 mRNA expression were scored. Gde2+/ animals
were generated by standard procedures involving targeted recombination of
the Gde2 locus in ES cells. Disruption of the Gde2 allele in animals was
confirmed by Southern blotting, polymerase chain reaction (PCR), and immu-
nohistochemistry. ForGde2+/andPrdx1-null mutant analyses, 15–20 sections
from five embryos were counted.
For gain-of-function experiments, electroporated embryos were BrdU
labeled to define the lateral extent of the VZ (Rao and Sockanathan, 2005).
Images of 10–20 sections per embryo (n = 5–10 embryos) were scored.
Sections were chosen to ensure equivalent electroporation efficiency by
LacZ (GDE2) and HA (Prdx1) staining. All mutant and deletion constructs
were generated by site-directed (QuikChange Kit, Stratagene) or PCR-based
mutagenesis.
Cell-Cycle Analysis
Pregnant dams were injected with BrdU (100 mg/kg body weight) 30 min and
16 hr prior to embryo harvest for calculation of S-phase and cell-cycle exit
indices, respectively. S-phase: BrdU+/Ki67+ cells where Ki67 marks all cycling
cells; cell-cycle exit: BrdU+, Ki67-/BrdU+, Ki67+; mitotic index: Mpm2+/Ki67+,
where Mpm2 marks cells in mitosis (Chenn and Walsh, 2002).
Biochemical Experiments
Coimmunoprecipitation studies using FLAG-GDE2 and HA- or myc-Prdx1
transfected in HEK293 cells were performed with GammaBind G Sepharose
beads (Amersham). Western blotting was performed using HA-HRP (F7,
1:10,000, Santa Cruz) or polyclonal GDE2 antibodies (1:200,000).
GDE2 oxidation states were analyzed by redox western blots on surface
biotinylated GDE2 protein in transfected HEK293T cells. Transfected cells
were washed with cold phosphate-buffered saline (PBS) and biotinylated
with sulfo-NHS-SS-Biotin (Pierce) (1 mg/ml) at 4C for 30 min. Cells were
treated with 10% (w/v) TCA (4C, 30 min), and proteins were centrifuged
and washed with 100% acetone. Protein precipitates were suspended in
80 mM Tris-HCl (pH 6.8), 2% SDS, 6 M urea, 1 mM PMSF with 20 mM AMS
(Molecular probes), and the samples adjusted to neutral pH with 1 M Tris-
HCl (pH 7.5). AMS labeling was done on ice (15 min), at 37C (20 min), and
boiled for 2 min, and samples were immunoprecipitated by immobilized mono-
meric avidin (Pierce). Eluted proteins were deglycosylated with 25 U/ml
PNGase F (New England Biolabs) before resolving by nonreducing SDS-
PAGE. GDE2 was detected by western blotting using GDE2 antibodies.Cell 138, 1209–1221, September 18, 2009 ª2009 Elsevier Inc. 1219
To detect disulfide bonds, transfected cells were washed with cold
PBS supplemented with 10 mM NEM (Sigma), lysed in 10 mM Tris (pH 7.0),
150 mM NaCl, 1% NP-40, 0.1% SDS with 40 mM NEM and proteinase inhib-
itors at 4C for 30 min, and centrifuged. Supernatants were acetone precipi-
tated at 20C, washed with 70% acetone, resolubilized in HENS buffer
(250 mM HEPES [pH 7.7], 1 mM EDTA, 1% SDS) with 5 mM TCEP, and incu-
bated for 1 hr to reduce disulfide bonds. The reaction was quenched with
acetone, and proteins were precipitated and washed as above. Pellets were
resolubilized in HENS with 0.5 mM biotin-HPDP (Pierce). Biotin labeling was
carried out at room temperature for 90 min, the reaction quenched by acetone
precipitation, and the pellet resolubilized in 25 mM HEPES (pH 7.7), 0.1 mM
EDTA, 0.75% SDS and diluted with 6 volumes of 1%Triton in TBS. GDE2
was immunoprecipitated using anti-FLAG M2 Affinity gel and western blots
were probed with antibodies against biotin (1:10,000, Sigma) and GDE2.
GDE2 protein was similarly labeled for LC-MS/MS; however, 10 mM DTT
was used instead of TCEP and 40 mM IAM was used instead of biotin-
HPDP. GDE2 was immunoprecipitated by anti-FLAG M2 Affinity gel, resolved
by SDS-PAGE and stained with Coomassie blue. Cysteines were identified by
LC-MS/MS (Taplin Biological Mass Spectrometry Facility).
Trapping of mixed disulfides between GDE2 and Prdx1 was performed by
standard immunoprecipitation with anti-FLAG M2 Affinity gel except that
100 mM of the thiol-alkylating agent maleimide was present in all solutions
to block free thiol groups and prevent thiol-disulfide exchange or thiol oxida-
tion (Burgoyne et al., 2007). Protein complexes were eluted by nonreducing
sample buffer and divided into two equal fractions, one of which was reduced
with 10% b-ME before analysis by SDS-PAGE. Prdx1 and Prdx1-GDE2
disulfide intermediates were detected by western blotting using rabbit anti-
HA antibodies (1:200, Y11, Santa Cruz).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and ten
figures and can be found with this article online at http://www.cell.com/
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